Orlando, Fla. - The cardiac catheterization laboratory is not only a place for diagnosis and treatment, but, also one of discovery. This perspective will be addressed in the Society for Cardiovascular Angiography and Interventions (SCAI) 2016 Mullins Lecture by Andrew Redington, MD, chief of cardiology and executive co-director of the Heart Institute at Cincinnati Children's Hospital Medical Center, and professor of pediatrics at University of Cincinnati College of Medicine. The lecture, "The Failing Subpulmonary Right Ventricle: Can Catheter Intervention Alter the Course?" will take place at the SCAI 2016 Scientific Sessions in Orlando, Fla.
"There is a tremendous opportunity for interventional cardiologists to continue to be pioneers and develop new treatment options for their patients," said Dr. Redington. "Over the past three decades, the advances we've made on the failing subpulmonary right ventricle is a good example of how we were able to move the needle."
Dr. Redington started his research on the failing subpulmonary right ventricle in the late 1980s in England. His research was instrumental in forming cardiologists' understanding of the impact of surgery on the right side of the heart. The concepts and techniques he introduced have led to fundamental changes in management of heart disease.
"Thirty years ago, my peers and professors thought I was crazy to look at the right ventricle, as it was considered unimportant," said Dr. Redington. "The entire field was ignoring it, but I felt that we needed to understand it better. Now, it's practically an entire field on its own, and we know it's a fundamental aspect of circulation in patients with congenital heart disease. It's come full circle."
Dr. Redington will discuss catheter intervention, the science behind the practice and what the future holds for the field. He will also address the impact of stenting on cardiology and how discoveries in the future can be made in a more facile way.
Dr. Redington's clinical interests and research focus on ventricular function, integrated physiology of congenital heart disease, and ischemic preconditioning. He currently holds more than 15 U.S. and international patents and has written more than 350 peer-reviewed articles.
The SCAI 2016 Mullins Lecture will be held on Thursday May 5, 2016 at 12:50 p.m. ET at the Hyatt Regency in Orlando, Fla.
For more information about the SCAI 2016 Scientific Sessions, visit http://www. SCAI.org/SCAI2016.
The Society for Cardiovascular Angiography and Interventions is a 4,500-member professional organization representing invasive and interventional cardiologists in approximately 70 nations. SCAI's mission is to promote excellence in invasive/interventional cardiovascular medicine through physician education and representation, and advancement of quality standards to enhance patient care. SCAI's public education program, Seconds Count, offers comprehensive information about cardiovascular disease. For more information about SCAI and Seconds Count, visit http://www.